Annexon Inc (ANNX)
4.368
-0.13
(-2.93%)
USD |
NASDAQ |
May 16, 16:00
4.368
0.00 (0.00%)
After-Hours: 20:00
Annexon 1 Year Total Returns (Daily): -25.74% for May 15, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 15, 2024 | -25.74% |
| May 14, 2024 | -11.72% |
| May 13, 2024 | -10.81% |
| May 10, 2024 | -15.78% |
| May 09, 2024 | -7.10% |
| May 08, 2024 | -7.24% |
| May 07, 2024 | -10.16% |
| May 06, 2024 | -8.64% |
| May 03, 2024 | -3.75% |
| May 02, 2024 | -4.51% |
| May 01, 2024 | -12.84% |
| April 30, 2024 | -14.23% |
| April 29, 2024 | -11.40% |
| April 26, 2024 | -12.15% |
| April 25, 2024 | -15.93% |
| April 24, 2024 | -21.79% |
| April 23, 2024 | -20.86% |
| April 22, 2024 | -18.98% |
| April 19, 2024 | -12.14% |
| April 18, 2024 | -13.79% |
| April 17, 2024 | -3.88% |
| April 16, 2024 | 5.68% |
| April 15, 2024 | 18.60% |
| April 12, 2024 | 24.32% |
| April 11, 2024 | 28.60% |
| Date | Value |
|---|---|
| April 10, 2024 | 38.50% |
| April 09, 2024 | 47.63% |
| April 08, 2024 | 43.36% |
| April 05, 2024 | 53.98% |
| April 04, 2024 | 60.71% |
| April 03, 2024 | 63.29% |
| April 02, 2024 | 66.75% |
| April 01, 2024 | 72.21% |
| March 28, 2024 | 85.27% |
| March 27, 2024 | 101.3% |
| March 26, 2024 | 79.63% |
| March 25, 2024 | 73.37% |
| March 22, 2024 | 80.37% |
| March 21, 2024 | 52.63% |
| March 20, 2024 | 43.83% |
| March 19, 2024 | 49.39% |
| March 18, 2024 | 54.55% |
| March 15, 2024 | 59.29% |
| March 14, 2024 | 24.72% |
| March 13, 2024 | 29.96% |
| March 12, 2024 | 5.52% |
| March 11, 2024 | 3.45% |
| March 08, 2024 | -0.60% |
| March 07, 2024 | 0.00% |
| March 06, 2024 | 18.82% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.99%
Minimum
Apr 18 2022
144.1%
Maximum
Apr 18 2023
-35.23%
Average
-45.32%
Median
Jan 10 2023
1 Year Total Returns (Daily) Benchmarks
| Trxade Health Inc | 78.49% |
| P3 Health Partners Inc | -79.72% |
| Arrowhead Pharmaceuticals Inc | -37.23% |
| Insmed Inc | 29.37% |
| Heron Therapeutics Inc | 125.6% |